PROGNOSTIC STAGING SYSTEM FOR RECURRENT, PERSISTENT, AND 2ND PRIMARY CANCERS OF THE ORAL CAVITY AND OROPHARYNX

Citation
B. Yueh et al., PROGNOSTIC STAGING SYSTEM FOR RECURRENT, PERSISTENT, AND 2ND PRIMARY CANCERS OF THE ORAL CAVITY AND OROPHARYNX, Archives of otolaryngology, head & neck surgery, 124(9), 1998, pp. 975-981
Citations number
25
Categorie Soggetti
Otorhinolaryngology,Surgery
ISSN journal
08864470
Volume
124
Issue
9
Year of publication
1998
Pages
975 - 981
Database
ISI
SICI code
0886-4470(1998)124:9<975:PSSFRP>2.0.ZU;2-R
Abstract
Objective: To develop a practical staging system for predicting mortal ity of patients with recurrent squamous cell tumors of the oral cavity and oropharyngeal mucosa. Design and Setting: An inception cohort at an academic medical center. Patients: A total of 308 patients who had evidence of recurrent, persistent, or second primary tumors of the ora l cavity and oropharynx between January 1, 1980, and December 31, 1991 , of whom 162 (52.6%) met inclusion criteria. Main Outcome Measure: On e-year mortality. Results: The median survival time was 10 months. In bivariate analysis, the TNM stage of the recurrent tumor, invasion of pharyngeal constrictors and the floor-of-mouth muscles, weight loss, l ocal and systemic symptoms, and eating function had significant effect s on mortality. Multivariable analysis (done by conjunctive consolidat ion and Cox regression) identified constrictor invasion, the TNM stage of the recurrence, and weight loss as having a substantial effect on mortality. A composite 4-stage system using these 3 variables demarcat ed 1-year survival rates of 88.2% (30/34), 71.9% (23/32), 32.6% (16/49 ), and 4.2% (2/47). Conclusions: The TNM status of recurrent tumors pr edicts mortality, but constrictor muscle invasion and weight loss also have major prognostic importance. The consolidation of these variable s into a composite staging system successfully stratifies patients wit h widely divergent mortality rates. Improved staging of recurrent head and neck tumors can lead to more effective decisions about the compar isons and merits of additional treatment.